These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 15275706)

  • 1. Unusual compulsive motor activity during treatment with clothiapine in a mentally retarded adolescent.
    Coppola G; Morelli E; Bravaccio C; Federico R; Gritti A
    Brain Dev; 2004 Sep; 26(6):409-11. PubMed ID: 15275706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case study: emergence of transient compulsive symptoms during treatment with clothiapine.
    Toren P; Samuel E; Weizman R; Golomb A; Eldar S; Laor N
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1469-72. PubMed ID: 8543514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacotherapy of disruptive behavior in mentally retarded subjects: A review of the current literature.
    Hässler F; Reis O
    Dev Disabil Res Rev; 2010; 16(3):265-72. PubMed ID: 20981765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth differences associated with compulsive and stereotyped behavior disorders in adults with mental retardation.
    Powell SB; Bodfish JW; Parker DE; Crawford TW; Golden RN; Lewis MH
    Anxiety; 1996; 2(2):90-4. PubMed ID: 9160607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
    Aman MG; Gharabawi GM;
    J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clozapine-induced tardive dyskinesia: a case report.
    Ertugrul A; Demir B
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 May; 29(4):633-5. PubMed ID: 15866369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-related exacerbation of obsessive-compulsive symptoms with quetiapine treatment.
    Chen CH; Chiu CC; Huang MC
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):304-5. PubMed ID: 17826882
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuroleptic malignant syndrome with use of quetiapine in mental retardation.
    Dan A; Bharadwaj R; Grover S
    Psychiatry Clin Neurosci; 2009 Apr; 63(2):255-6. PubMed ID: 19335404
    [No Abstract]   [Full Text] [Related]  

  • 9. Quetiapine-induced obsessive-compulsive symptoms: a series of five cases.
    Stamouli S; Lykouras L
    J Clin Psychopharmacol; 2006 Aug; 26(4):396-400. PubMed ID: 16855458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obsessive-compulsive symptoms and disorder in patients with schizophrenia treated with clozapine or haloperidol.
    Sa AR; Hounie AG; Sampaio AS; Arrais J; Miguel EC; Elkis H
    Compr Psychiatry; 2009; 50(5):437-42. PubMed ID: 19683614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pharmacological management of aggressive and autoaggressive behaviour in mentally retarded patients with melperone (author's transl)].
    Hacke W
    Pharmakopsychiatr Neuropsychopharmakol; 1980 Jan; 13(1):20-4. PubMed ID: 6102772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clozapine-induced obsessive-compulsive disorder: a case report].
    Sánchez Bonome L; Barjau Romero JM; Lara Muñoz Rd; Márquez Tejero MC
    Actas Esp Psiquiatr; 2002; 30(5):330-4. PubMed ID: 12372230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obsessive compulsive symptoms associated with quetiapine treatment in a schizophrenic patient: a case report.
    Ozer S; Arsava M; Ertuğrul A; Demir B
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jun; 30(4):724-7. PubMed ID: 16414169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. De novo induction of obsessive-compulsive symptoms with quetiapine in a patient with borderline personality disorder.
    Alexander J
    Aust N Z J Psychiatry; 2009 Dec; 43(12):1185. PubMed ID: 20001420
    [No Abstract]   [Full Text] [Related]  

  • 15. Tardive dyskinesia in mentally retarded children, adolescents, and young adults: North Carolina and Michigan studies.
    Gualtieri CT; Breuning SE; Schroeder SR; Quade D
    Psychopharmacol Bull; 1982 Jan; 18(1):62-5. PubMed ID: 6152872
    [No Abstract]   [Full Text] [Related]  

  • 16. [The syndrome of inappropriate antidiuretic hormone secretion (SIADH) during treatment with the antipsychotic agents haloperidol and quetiapine].
    van den Heuvel OA; Bet PM; van Dam EW; Eeckhout AM
    Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1944-8. PubMed ID: 16999280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural disorders induced by external globus pallidus dysfunction in primates: I. Behavioural study.
    Grabli D; McCairn K; Hirsch EC; Agid Y; Féger J; François C; Tremblay L
    Brain; 2004 Sep; 127(Pt 9):2039-54. PubMed ID: 15292053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aggression and disruptive behavior disorders in children and adolescents.
    Turgay A
    Expert Rev Neurother; 2004 Jul; 4(4):623-32. PubMed ID: 15853581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High vulnerability to acute dystonic reactions: a case of antipsychotic exposure and uncontrolled seizure activity.
    Coffey GL; Botts SR; de Leon J
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):770-4. PubMed ID: 15927338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.